Concord Biotech Ltd KYS Report: Ownership & Insights | Research 360

15:43 Dec 16

Concord Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

1379.40

+18.80 (+1.38%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Concord Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology 15:43 Dec 16

1379.40

+18.80 (+1.38%)

64/100 High Financial Strength

Quality

26/100 Expensive Valuation

Valuation

28/100 Technically Bearish

Technical

SWOT

Strength

8

Weakness

7

Opportunity

0

Threat

1

14.43K

Market Cap (Cr)

44.55

PE Ratio

7.79

Price to Book Ratio

35.94

RSI

30.96 %

Net Profit Margin

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password